CD8A and COVID-19: The small number of participants in this pilot study makes it difficult to conclude whether the observed trends in increased percentages of CD8+ T cells in the peripheral blood of COVID-19 convalescent patients at the 4-month follow up scans are due to the heterogeneity of patients with COVID-19, clinical differences among the subjects of this study with those of previous studies, or methodological variations.